TOBAM - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
TOBAM ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$12,485,000
-19.0%
784,818
+6.5%
0.51%
-23.1%
Q4 2017$15,405,000
+1.7%
736,718
-30.5%
0.67%
+16.6%
Q3 2017$15,145,000
-22.2%
1,059,318
-5.5%
0.57%
-21.3%
Q2 2017$19,458,000
+46.3%
1,121,113
-7.2%
0.73%
+41.4%
Q1 2017$13,304,000
-7.2%
1,207,818
+22.4%
0.51%
-12.0%
Q4 2016$14,332,000
-15.5%
987,118
+42.6%
0.58%
-4.3%
Q3 2016$16,952,000
+11.5%
692,118
-8.7%
0.61%
+0.2%
Q2 2016$15,210,000
+31.4%
758,300
+72.5%
0.61%
+33.6%
Q1 2016$11,575,000
-40.8%
439,700
+127.5%
0.46%
-46.0%
Q4 2015$19,560,000
+128.7%
193,300
+301.5%
0.84%
+153.0%
Q3 2015$8,553,000
-38.9%
48,144
-23.7%
0.33%
-34.6%
Q2 2015$14,004,000
+148.7%
63,100
+121.4%
0.51%
+197.1%
Q1 2015$5,631,000
+503.5%
28,500
+338.5%
0.17%
+454.8%
Q4 2014$933,000
+72.8%
6,500
+58.5%
0.03%
+14.8%
Q1 2014$540,000
-95.7%
4,100
-96.2%
0.03%
-95.8%
Q4 2013$12,491,000
-22.1%
106,500
-30.6%
0.64%
-28.7%
Q3 2013$16,039,000
+106.6%
153,500
+70.0%
0.90%
+75.9%
Q2 2013$7,762,00090,3000.51%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2016
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders